ArticleCureus2025
Proliferative Glomerulonephritis With Monoclonal Immunoglobulin G Deposits (PGNMID) With Chronic-Type Thrombotic Microangiopathy (TMA): A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Proliferative glomerulonephritis with monoclonal immunoglobulin G (IgG) deposits (PGNMID) is a form of monoclonal gammopathy of renal significance. A pathological evaluation of a kidney biopsy is essential for the diagnosis of PGNMID because it is characterized by glomerulonephritis with exclusively glomerular monotypic immunoglobulin deposits, which are typically IgG, and less commonly IgM or IgA. Membranoproliferative glomerulonephritis and endocapillary proliferative glomerulonephritis are the typical pathological features of PGNMID. A 53-year-old Japanese woman presented with persistent proteinuria for more than 10 years. The patient had a medical history of unknown acute kidney injury 20 years previously and received a 1-year course of steroid therapy. She was later diagnosed with nephrosclerosis and received angiotensin II receptor blocker (ARB) therapy for over two years; however, her proteinuria gradually worsened, and renal function declined. A kidney biopsy revealed focal segmental endocapillary hypercellularity with mild mesangial proliferation and double contours of glomerular basement membranes. Immunofluorescence showed granular staining for IgG, C3, C1q, IgG3, and λ in the mesangial areas and along the glomerular capillary walls. Electron microscopy demonstrated electron-dense deposits without organized structures in the paramesangial and mesangial areas, together with subendothelial edema and new basement membrane formation. These findings did not conform to the typical membranoproliferative pattern, leading to a diagnosis of PGNMID with chronic thrombotic microangiopathy (TMA). In addition to ongoing ARB therapy, corticosteroid treatment reduced proteinuria and stabilized renal function. To our knowledge, this is a rare case of PGNMID that was accompanied by chronic TMA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.